ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,018.39
-0.34%
US Tech 100
17,006.40
0.86%
다우존스 지수
37,903.29
0.23%
Bitcoin
57,689.90
-0.94%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Poseida Therapeutics Inc (PSTX)

  7. Poseida Therapeutics Inc (PSTX) 뉴스

PSTX Poseida Therapeutics Inc

2.85
0.08 (2.89%)
시간외 단일가
최종 업데이트: 19:22:39
15분 지연
기업명 주식 심볼 시장 주식 타입
Poseida Therapeutics Inc PSTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.08 2.89% 2.85 19:22:39
개장가 저가 고가 종가 전일 종가
2.77
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202410:30PRNUSAstellas and Poseida Therapeutics Enter Into Research..
02/05/202404:25APSBiotech Soars on Research Collaboration And License..
01/05/202422:00PRNUSAstellas and Poseida Therapeutics Enter Into Research..
18/04/202421:00PRNUSPoseida Therapeutics Announces Strong Lineup of..
17/04/202422:00PRNUSPoseida Therapeutics Hosts Gene Therapy R&D Day Highlighting..
09/04/202401:00PRNUSPoseida Therapeutics Presents New Phase 1 Data at AACR 2024..
02/04/202405:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
26/03/202405:05PRNUSPoseida Therapeutics Appoints Syed Rizvi, M.D., as Chief..
20/03/202405:05PRNUSPoseida Therapeutics to Present at H.C. Wainwright 2nd..
14/03/202405:05PRNUSPoseida Therapeutics Announces FDA Orphan Drug Designation..
08/03/202406:07PRNUSPoseida Therapeutics Provides Updates and Financial Results..
08/03/202406:05EDGAR2Form 8-K - Current report
05/03/202407:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
09/02/202406:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/01/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:01EDGAR2Form 8-K - Current report
04/01/202422:00PRNUSPoseida Therapeutics Highlights Recent Progress, Strategic..
12/12/202300:31DJNPoseida Therapeutics Shares Climb on Positive Data for Blood..
11/12/202320:06EDGAR2Form 8-K - Current report
11/12/202302:00PRNUSPoseida Therapeutics Presents Positive Early Results from..
10/11/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:05EDGAR2Form 8-K - Current report
10/11/202306:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..
07/11/202322:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
02/11/202322:01PRNUSPoseida Therapeutics to Present at the 65th ASH Annual..
10/10/202305:30PRNUSPoseida Therapeutics Announces Leadership Transition
05/09/202321:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
15/08/202305:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
12/08/202305:48EDGAR2Form D - Notice of Exempt Offering of Securities
09/08/202305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:06EDGAR2Form 8-K - Current report
09/08/202305:05PRNUSPoseida Therapeutics Provides Financial Results for the..
07/08/202323:41DJNPoseida Therapeutics Shares Leap on Astellas Investments
07/08/202322:58DJNPoseida Therapeutics in $50 Million Investment Deal With..
07/08/202322:01EDGAR2Form 8-K - Current report
07/08/202322:01PRNUSPoseida Therapeutics Announces Strategic Investment by..
07/08/202322:00PRNUSAstellas and Poseida Therapeutics Announce Strategic..
05/07/202321:00PRNUSPoseida Therapeutics Announces FDA Clearance of..
26/06/202321:00PRNUSPoseida Therapeutics to Join Russell 3000® and Russell 2000®..
01/06/202321:00PRNUSPoseida Therapeutics Announces Virtual 2023 Annual Meeting..
23/05/202321:00PRNUSPoseida Therapeutics to Present at Stifel 2023 Tailoring..
22/05/202321:00PRNUSPoseida Therapeutics to Present at 31st Congress of the..
18/05/202321:00PRNUSPoseida Therapeutics Presents Encouraging Preclinical Data..
10/05/202305:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..

최근 히스토리

NASDAQ
PSTX
Poseida Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유